GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of small win: compounding stopped being a problem at week 40 — 21 comments in the full submission. View in context.
507
c/compounding·submitted 3 months ago by u/santiago_rasmussen

small win: compounding stopped being a problem at week 40

Explainerbranch of 4 comments

Something I noticed reading old threads that I have not seen said out loud. The advice on shortage list in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers…

Read the full submission and all 21 comments →

This branch

4 comments, started 3 months ago
u/prior_auth_painappeals60 points·3 months ago

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/santiago_rasmussenOP43 points·3 months ago

The telehealth + compounding combo cost telehealth plus 8% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/escrow_evangelist34 points·3 months ago·edited

API transparency is the question that separates good compounders from sketchy ones

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →